Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

huC242-DM4: preclinical studies and a phase I trial

Nov. 8, 2007

Phase III mifamurtide data confirms superior overall survival in osteosarcoma

Nov. 8, 2007

Phase I trial compares daily, twice daily ARRY-543 in patients with solid tumors

Nov. 8, 2007

Sunitinib safe and active in phase II hepatocellular carcinoma study

Nov. 8, 2007

Protox presents positive final data from PRX-302 prostate cancer study

Nov. 7, 2007

Progen receives fast track status and plans to initiate phase III trial for PI-88 for liver cancer

Nov. 7, 2007

Poniard initiates phase II trial of picoplatin for metastatic colorectal cancer

Nov. 7, 2007

ENMD-1198 metabolism, pharmacokinetics studied in humans

Nov. 7, 2007

Escalating doses of CR011-vcMMAE assessed in melanoma patients

Nov. 7, 2007

Novel rexinoid compound with promising anticancer activity in experimental breast and lung cancer

Nov. 7, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...